These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19853701)

  • 1. Histologic characterization of hypertrophic cardiomyopathy with and without myofilament mutations.
    McLeod CJ; Bos JM; Theis JL; Edwards WD; Gersh BJ; Ommen SR; Ackerman MJ
    Am Heart J; 2009 Nov; 158(5):799-805. PubMed ID: 19853701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial fibrosis in patients with symptomatic obstructive hypertrophic cardiomyopathy: correlation with echocardiographic measurements, sarcomeric genotypes, and pro-left ventricular hypertrophy polymorphisms involving the renin-angiotensin-aldosterone system.
    Blauwet LA; Ackerman MJ; Edwards WD; Riehle DL; Ommen SR
    Cardiovasc Pathol; 2009; 18(5):262-8. PubMed ID: 18835191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: septal morphological features predict the presence of myofilament mutations.
    Binder J; Ommen SR; Gersh BJ; Van Driest SL; Tajik AJ; Nishimura RA; Ackerman MJ
    Mayo Clin Proc; 2006 Apr; 81(4):459-67. PubMed ID: 16610565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene-specific modifying effects of pro-LVH polymorphisms involving the renin-angiotensin-aldosterone system among 389 unrelated patients with hypertrophic cardiomyopathy.
    Perkins MJ; Van Driest SL; Ellsworth EG; Will ML; Gersh BJ; Ommen SR; Ackerman MJ
    Eur Heart J; 2005 Nov; 26(22):2457-62. PubMed ID: 16087648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms in the renin-angiotensin-aldosterone system associated with expression of left ventricular hypertrophy in hypertrophic cardiomyopathy: a study of five polymorphic genes in a family with a disease causing mutation in the myosin binding protein C gene.
    Ortlepp JR; Vosberg HP; Reith S; Ohme F; Mahon NG; Schröder D; Klues HG; Hanrath P; McKenna WJ
    Heart; 2002 Mar; 87(3):270-5. PubMed ID: 11847170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Echocardiographic-determined septal morphology in Z-disc hypertrophic cardiomyopathy.
    Theis JL; Bos JM; Bartleson VB; Will ML; Binder J; Vatta M; Towbin JA; Gersh BJ; Ommen SR; Ackerman MJ
    Biochem Biophys Res Commun; 2006 Dec; 351(4):896-902. PubMed ID: 17097056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression patterns of cardiac myofilament proteins: genomic and protein analysis of surgical myectomy tissue from patients with obstructive hypertrophic cardiomyopathy.
    Theis JL; Bos JM; Theis JD; Miller DV; Dearani JA; Schaff HV; Gersh BJ; Ommen SR; Moss RL; Ackerman MJ
    Circ Heart Fail; 2009 Jul; 2(4):325-33. PubMed ID: 19808356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deformation patterns in genotyped patients with hypertrophic cardiomyopathy.
    Geske JB; Bos JM; Gersh BJ; Ommen SR; Eidem BW; Ackerman MJ
    Eur Heart J Cardiovasc Imaging; 2014 Apr; 15(4):456-65. PubMed ID: 24217980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy.
    Olivotto I; Girolami F; Ackerman MJ; Nistri S; Bos JM; Zachara E; Ommen SR; Theis JL; Vaubel RA; Re F; Armentano C; Poggesi C; Torricelli F; Cecchi F
    Mayo Clin Proc; 2008 Jun; 83(6):630-8. PubMed ID: 18533079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Spectrum and Management Implications of Left Ventricular Outflow Obstruction With Mild Ventricular Septal Thickness in Hypertrophic Cardiomyopathy.
    Rowin EJ; Maron BJ; Chokshi A; Kannappan M; Arkun K; Wang W; Rastegar H; Maron MS
    Am J Cardiol; 2018 Oct; 122(8):1409-1420. PubMed ID: 30107902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between sex, shape, and substrate in hypertrophic cardiomyopathy.
    Bos JM; Theis JL; Tajik AJ; Gersh BJ; Ommen SR; Ackerman MJ
    Am Heart J; 2008 Jun; 155(6):1128-34. PubMed ID: 18513529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RAAS gene polymorphisms influence progression of pediatric hypertrophic cardiomyopathy.
    Kaufman BD; Auerbach S; Reddy S; Manlhiot C; Deng L; Prakash A; Printz BF; Gruber D; Papavassiliou DP; Hsu DT; Sehnert AJ; Chung WK; Mital S
    Hum Genet; 2007 Dec; 122(5):515-23. PubMed ID: 17851694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular hypertrophy and morphology in familial hypertrophic cardiomyopathy associated with mutations of the beta-myosin heavy chain gene.
    Solomon SD; Wolff S; Watkins H; Ridker PM; Come P; McKenna WJ; Seidman CE; Lee RT
    J Am Coll Cardiol; 1993 Aug; 22(2):498-505. PubMed ID: 8335820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical pathology of subaortic septal myectomy: histology skips over clinical diagnosis.
    Abecasis J; Gouveia R; Castro M; Andrade MJ; Ribeiras R; Ramos S; Abecasis M; Cardim N; Gil V
    Cardiovasc Pathol; 2018; 33():32-38. PubMed ID: 29414430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between septal strain rate and histopathology in symptomatic hypertrophic cardiomyopathy patients undergoing septal myectomy.
    Kobayashi T; Popovic Z; Bhonsale A; Smedira NG; Tan C; Rodriguez ER; Thamilarasan M; Lytle BW; Lever HM; Desai MY
    Am Heart J; 2013 Sep; 166(3):503-11. PubMed ID: 24016500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of polymorphisms in the renin-angiotensin-aldosterone system on hypertrophic cardiomyopathy.
    Orenes-Piñero E; Hernández-Romero D; Jover E; Valdés M; Lip GY; Marín F
    J Renin Angiotensin Aldosterone Syst; 2011 Dec; 12(4):521-30. PubMed ID: 21507890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of Hypertrophic Cardiomyopathy is Mutation Rather Than Disease Specific: A Comparison of the Cardiac Troponin T E163R and R92Q Mouse Models.
    Ferrantini C; Coppini R; Pioner JM; Gentile F; Tosi B; Mazzoni L; Scellini B; Piroddi N; Laurino A; Santini L; Spinelli V; Sacconi L; De Tombe P; Moore R; Tardiff J; Mugelli A; Olivotto I; Cerbai E; Tesi C; Poggesi C
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28735292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertrophic obstructive cardiomyopathy: preoperative echocardiographic predictors of outcome after septal myectomy.
    McCully RB; Nishimura RA; Bailey KR; Schaff HV; Danielson GK; Tajik AJ
    J Am Coll Cardiol; 1996 May; 27(6):1491-6. PubMed ID: 8626964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations.
    Olivotto I; Girolami F; Sciagrà R; Ackerman MJ; Sotgia B; Bos JM; Nistri S; Sgalambro A; Grifoni C; Torricelli F; Camici PG; Cecchi F
    J Am Coll Cardiol; 2011 Aug; 58(8):839-48. PubMed ID: 21835320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of tissue Doppler to distinguish discrete upper ventricular septal hypertrophy from obstructive hypertrophic cardiomyopathy.
    Chen-Tournoux A; Fifer MA; Picard MH; Hung J
    Am J Cardiol; 2008 May; 101(10):1498-503. PubMed ID: 18471465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.